Innovation Pharmaceuticals Inc (IPIX)

[TOB]

No big deal at all.

I raised my concern on this very point and people told me it was no big deal. We are already at 100M outstanding and the additional financing will cause that number to only go up. For a stock that is so early in the process, it is a bit concerning.

CTIX is hardly "early in the process" with one potential blockbuster drug kevertrin in Phase 1 clinical trials and another potential blockbuster drug prurisol entering clinical trials concurrently.

Another 10 or 20 million shares would be inconsequential, be book neutral for Cellceutix as it raises money, the same for shareholders for own a lower percentage of a company with higher value.

It would be a very good thing for shareholders in fact as it gives Cellceutix the money needed to create shareholder value.

Not a concern at all. Quite normal in fact. This is what public companies do, they raise money to create shareholder value.

Cellceutix is not raising money just to pay executive's salaries. So any fund raising at this point would be part of a Virtuous Cycle, a wonderful thing for shareholders.

This is economics 101.